Michael G Carter - Net Worth and Insider Trading
Michael G Carter Net Worth
The estimated net worth of Michael G Carter is at least $31,456 dollars as of 2024-05-03. Michael G Carter is the Director of Oncternal Therapeutics Inc and owns about 3,597 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $31,456. Details can be seen in Michael G Carter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael G Carter has not made any transactions after 2020-09-01 and currently still holds the listed stock(s).
Transaction Summary of Michael G Carter
Michael G Carter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael G Carter owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Michael G Carter’s form 4 insider trades.
Insider Ownership Summary of Michael G Carter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-09-01 | director |
Michael G Carter Latest Holdings Summary
Michael G Carter currently owns a total of 1 stock. Michael G Carter owns 3,597 shares of Oncternal Therapeutics Inc (ONCT) as of September 1, 2020, with a value of $31,456.
Latest Holdings of Michael G Carter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-09-01 | 3,597 | 8.75 | 31,456 |
Holding Weightings of Michael G Carter
Michael G Carter Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael G Carter has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 3,571 shares on September 1, 2020, which cost Michael G Carter around $150,001.
Insider Trading History of Michael G Carter
- 1
Michael G Carter Trading Performance
GuruFocus tracks the stock performance after each of Michael G Carter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael G Carter is 46.73%. GuruFocus also compares Michael G Carter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael G Carter within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael G Carter's insider trading performs compared to the benchmark.
Performance of Michael G Carter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.06 | | | | | |
| Relative Return to S&P 500(%) | -6.92 | | | | | |
Michael G Carter Ownership Network
Michael G Carter Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Michael G Carter is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Michael G Carter made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 980 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,980 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Michael G Carter Mailing Address
Above is the net worth, insider trading, and ownership report for Michael G Carter. You might contact Michael G Carter via mailing address: C/o Cancer Vax Corp, 2110 Rutherford Road, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
